Details for New Drug Application (NDA): 020542
✉ Email this page to a colleague
NDA 020542 describes DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%, which is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs. Additional details are available on the DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% profile page.
The generic ingredient in DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
The generic ingredient in DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
Summary for 020542
| Tradename: | DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% |
| Applicant: | Hospira |
| Ingredient: | dopamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020542
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1.6MG/ML | ||||
| Approval Date: | Aug 30, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
